Grand Journal of Urology
E-ISSN : 2757-7163

Publication Ethics

Publication Policies

Publication Policies have been prepared by Logos Medical Publishing, with the contributions of the Grand Journal of Urology Editorial Board, by examining the guidelines of the leading national and international institutions in the publishing sector.

Editorial policies of the Grand Journal of Urology are conducted as stated in the rules recommended by the Council of Science Editors and reflected in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http://www.icmje.org/). Accordingly, authors, reviewers, and editors are expected to adhere to the best practice guidelines on ethical behavior contained in this statement. It is recommended that all researchers who will send their studies to the journal should examine this guide carefully. The resources and international authorities used during the preparation process of these policies are indicated at the end of the guideline.

Articles should be prepared following the guidelines of ICMJE- Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org). Authors should prepare papers by following CONSORT guidelines (http://www.consort-statement.org) for randomized research studies, STROBE guidelines (http://www.strobe-statement.org) for original observational research studies, STARD guidelines (https://www.equator-network.org/reporting-guidelines/stard/) for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis (http://www.prisma-statement.org), ARRIVE guidelines for experimental animal studies (https://arriveguidelines.org/) and TREND directives for non-randomized public behavior (http://www.cdc.gov/trendstatement).

Copyright & Licensing

The manuscripts submitted to the Grand Journal of Urology for publication should possess the characteristic features of original work, and they must not have been previously published in any form or sent for publication at any time.

The Grand Journal of Urology has national and international copyright to all content published in the journal. The authors must agree to waive the copyright of their work and transfer it together with submitting their manuscript for evaluation to the Grand Journal of Urology. The Editorial Board is authorized to publish the article. However, the authors reserve their patent rights, all unregistered rights other than copyright, the right to reproduce the article for their purposes and use all or part of their article in their books. Other academic works (on the condition that they provide references) have the right to have it on their websites or in the university's open archive provided that they indicate the study's title. If rejected for publication, the copyright of the manuscript will be assigned back to the authors.

The authors who will send their works to our journal should fill in the "Copyright Transfer Form" and sign the completed form. All contributing authors should sign the copyright transfer form, and a scanned version of the wet signed document should be uploaded via the online submission system during the manuscript submission steps.

All published content in the Grand Journal of Urology is licensed under Creative Commons CC-BY-NC 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/). Under this license, the third parties and authors are allowed to reuse the articles for non-commercial purposes. The contents can be used as a reference in scientific publications and presentations.

Wages Policy

There is no charge for submission, processing, publishing, and no copyright fee is paid to the authors.

Open Access Policy

Open access is an approach that supports interdisciplinary development and encourages collaboration between different disciplines. Therefore, the Grand Journal of Urology contributes to the scientific publishing literature by providing more access to its articles and a more transparent review process.

Author (s) and the copyright owner (s) grant access to all users for the articles published in the Grand Journal of Urology free of charge. The Grand Journal of Urology publisher does not demand any subscription fee, publication fee, or similar payment to access electronic resources. Articles may be used provided that they are cited. 

Open Access Policy is based on Budapest Open Access Initiative (BOAI) (http://www.budapestopenaccessinitiative.org/). By "open access" to peer-reviewed research literature, we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, index, or link to the full text of these articles. Enter them as data into the software, and use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, is that the authors retain control over the integrity of their work and should be properly acknowledged and cited. 

A Creative Commons license is a public copyright license that provides free distribution of copyrighted works or studies. Authors use the CC license to transfer the right to use, share or modify their work to third parties. All published content in the Grand Journal of Urology is licensed under Creative Commons CC-BY-NC 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits third parties to share and adapt the content for non-commercial purposes by giving the appropriate credit to the original work.

CC BY-NC-ND includes the following elements:

BY – Credit must be given to the creator.
NC – Only non-commercial uses of the work are permitted
ND – No derivatives or adaptations of the work are permitted.

Ethics Policy

Submission is considered on the conditions that papers are previously unpublished and are not offered simultaneously elsewhere; that authors have read and approved the content, and all authors have also declared all competing interests; and that the work complies with the Ethical Approval and has been conducted under internationally accepted ethical standards. If ethical misconduct is suspected, the Editorial Board will follow the relevant international rules of publication ethics (i.e., COPE guidelines, https://publicationethics.org/).

Ethical committee approval is required for experimental, clinical, and pharmaceutical studies and some case reports under international agreements (World Medical Association Declaration of Helsinki "Ethical Principles for Medical Research Involving Human Subjects, www.wma.net). The Ethics Committee approval document should be submitted to the Grand Journal of Urology together with the manuscript.

For the experimental, clinical, and drug human studies, approval by ethical committee and a statement on the adherence of the study protocol to the international agreements (Helsinki Declaration revised 2008 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/) are required. In experimental animal studies, the authors should indicate that the procedures followed were by animal rights (Guide for the care and use of laboratory animals, https://www.nap.edu/catalog/5140/guide-for-the-care-and-use-of-laboratory-animals), and they should obtain animal ethics committee approval. The Ethics Committee approval document should be submitted to the Grand Journal of Urology together with the manuscript.

The approval of the ethics committee, statement on the adherence to international guidelines mentioned above, and that the patient's informed consent is obtained should be indicated in the `Material and Method` section and is required for case reports whenever data/media used could reveal the identity of the patient. The declaration of the conflict of interest between authors, institutions, acknowledgment of any financial or material support, aid is mandatory for authors submitting a manuscript, and the statement should appear at the end of the manuscript. Reviewers are required to report if any potential conflict of interest exists between the reviewer and authors, institutions.

Although retrospective studies are carried on currently available data or biological materials (official consent may not be required or challenging to obtain), ethical approval may depend on a country's laws and national codes of ethics. Author (s) should check with their institution to comply with their country's specific terms.

Ethics committee approval is required in accordance with the National Ulakbim TR Index criteria for research/orginal article studies using patients' data, even if they are retrospective, and this approval document should be attached when submitting the article.

In case reports, the author (s) must get informed consent from the individual (or parent or guardian if the participant is young or incompetent).

For photographs that can reveal patients' identities, the author (s) must get permission from the patient or their legal representative and attach evidence of such permission when submitting their article. Authors wanting to add figures, tables, or text sections published elsewhere must obtain permission from the copyright holders and include evidence of such permission when submitting their articles. Any material received without such evidence will be deemed to come from the author (s), and the legal, financial, and criminal responsibility in this respect will belong to the author (s).

Fabrication: To publish data and findings/results that do not exist.
Duplication: Used data from another publication; that includes republishing an article in different languages.
Salamisation: Creating multiple publications by supernaturally splitting the results of a study.

We disapprove of such unethical practices as plagiarism, fabrication, duplication, and salamisation and efforts to influence the review process with such practices as gifting authorship, inappropriate acknowledgements, and references. Submitted manuscripts are also subjected to the evaluation of plagiarism, duplicate publication by automatic software. Authors are obliged to acknowledge if they published study results in whole or in part in the form of abstracts.

Plagiarism

Plagiarism is the republishing of whole or part of the content in another author's publication without attribution and is an ethical violation, whether intentionally or not. It is a crime and an unacceptable code of conduct as it is unethical to submit and publish manuscripts imitating other sources, with or without citing references. Authors should not quote directly from other publications, and they should give their information by using their original sentences and citing the original publication. This situation also applies to self-citation. For this reason, due to publication policies, the Grand Journal of Urology, for all studies to be published in all of the periodicals, necessitates a plagiarism checker.

All submitted articles are scanned with similarity detection software (iThenticate) before being sent to the double-blind peer-review process and after passing the reviewers' evaluation and the limitation without similarity is 25%.

Our criterion is not a percentage of matching. A specialized team carries out auditing excluding percentages of matching but considering the parameters, such as identification of matching paragraphs, whether or not citations and references are appropriately written under the writing rules of the journal, the places of the matching sentences/paragraphs in the article, and the sources with which they are matched. The prepared plagiarism report is sent to the relevant editor of the study. In consideration of the report, the editorial board may request from the author correction of the errors in the manuscript and send it again or accept or reject it. The acceptance of the study is on the initiative of the Editor-in-Chief. In alleged or suspected research misconduct cases such as plagiarism, citation manipulation, and data fraud/fabrication, the Editorial Board will follow and act by the COPE guidelines (https://publicationethics.org/).

Conflict of Interest & Financial Disclosures

Conditions that provide financial or personal benefit bring about a conflict of interest. The reliability of the scientific process and the published articles is directly related to the objective consideration of conflicts of interest during the planning, implementation, writing, evaluation, editing, and publication of scientific studies.

Financial relations are the most easily identified conflicts of interest, and they will inevitably undermine the credibility of the journal, the authors, and the science. These conflicts can be caused by particular relations, academic competition, or philosophical approaches. The authors should refrain as much as possible from making agreements with sponsors in the opinion of gaining profit or any other advantage that restrict their ability to access all data of the study or analyze, interpret, prepare, and publish their articles. In order to prevent conflicts of interest, editors should refrain from bringing together those who may have any relationship with them during the evaluation of the studies. The editors, who make the final decision about the articles, should not have any personal, professional, or financial ties with any of the issues they will decide.

Author (s) should disclose any existing or potential conflicts of interest, including financial, consulting, and institutional, that could lead to potential bias or conflict of interest. Any financial grants or other support received from individuals or institutions should be informed to the Editorial Board. The Editorial Board resolves any potential conflict of interest of editors, authors, or referees within the context of COPE (https://publicationethics.org/) and ICMJE (http://www.icmje.org/) guidelines.

If one of the editors is an author in any manuscript, the editor is excluded from the manuscript evaluation process. In order to prevent any conflict of interest, the article evaluation process is carried out as double-blinded. Because of the double-blinded evaluation process, except for the Editor-in-Chief, none of the editorial board members, international advisory board members, or reviewers is informed about the authors of the manuscript or institutions.

Our publication team works devotedly to ensuring that the evaluation process is conducted impartially, considering all these situations.